PRKG1 and benign prostatic hyperplasia: Other studies have also reported that the cGMP/PKG signaling pathway may regulate the inflammatory response implicated in several pathological conditions, including BPH,11, 12, 13 but the mechanism of cGMP/PKG signaling and its specific role in inflammation in the prostate is not well understood.